PROTAC
Read More about this categoryShow Less
The PROTAC molecule itself contains three distinct portions: a ligand for binding to the target protein, a ligand for binding to an E3 ligase, and a linker joining these two ligands.
PROTACs (proteolysis-targeting chimaeras) are bifunctional molecules that bring a target protein into spatial proximity with an E3 ubiquitin ligase to trigger target ubiquitination and subsequent proteasomal degradation. Effective redirection of ligase poly-ubiquitination activity toward a new substrate protein requires formation of a ligase:PROTAC:target ternary complex, an intermediate species that is crucial to the cellular activity of degrader molecules. A characteristic feature of PROTACs mode of action is their sub-stoichiometric catalytic activity that alleviates the requirement for target engagement and occupancy of traditional inhibitors. New PROTAC molecules designed guided by the crystal structure show exquisite selectivity for inducing cellular depletion of Brd4 over its BET family members Brd2 and Brd3.
Products Related to PROTAC(273)
- GC81862YJ1206 TFAPurity: >98.00%
YJ1206 TFA is an orally active selective CDK12 / CDK13 PROTAC degrader.
- GC81882PROTAC CARM1 degrader-1 TFAPurity: >98.00%
PROTAC CARM1 degrader-1 TFA is a highly selective CARM1 PROTAC degrader, with a DC 50 of 8.1 nM in MCF‑7 cells.
- GC91582Pomalidomide 4'-PEG5-amine (hydrochloride)CAS: 2357117-23-6Purity: >95.00%
Pomalidomide 4’-PEG5-amine is a PEGylated form of the cereblon (CRBN) inhibitor pomalidomide .
- GC91584Pomalidomide 4'-alkylC6-amine (hydrochloride)CAS: 2375194-37-7Purity: >98.00%
Pomalidomide 4'-alkylC6-amine is a building block in the synthesis of proteolysis-targeting chimeras (PROTACs) and a derivative of the cereblon inhibitor pomalidomide .
- GC91586PROTAC RAF Degrader 1CAS: 2413035-41-1Purity: >98.00%
PROTAC RAF degrader 1 is a proteolysis-targeting chimera (PROTAC) that contains the inhibitor of mutant V600E and wild-type B-RAF vemurafenib (PLX4032; ) conjugated to VHL ligand 1 .
- GF04054PROTAC CDK9 degrader-4CAS: 2411021-01-5Purity: >95.00%
PROTAC CDK9 degrader-4 is a PROTAC protein degrader that targets CDK9 (cyclin-dependent kinase 9).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC81732 | iAfaPhos1 | - | >98% | |
iAfaPhos1 is a FKBP12F36V epimer ligand. | ||||
| GC81862 | YJ1206 TFA | - | >98.00% | |
YJ1206 TFA is an orally active selective CDK12 / CDK13 PROTAC degrader. | ||||
| GC81882 | PROTAC CARM1 degrader-1 TFA | - | >98.00% | |
PROTAC CARM1 degrader-1 TFA is a highly selective CARM1 PROTAC degrader, with a DC 50 of 8.1 nM in MCF‑7 cells. | ||||
| GC91440 | Dth | - | >95.00% | |
Dth est une chimère de ciblage de protéolyse (PROTAC) composée de la sonde fluorescente pour l'ARN DFHBI et du composé immunomodulateur thalidomide. | ||||
| GC91442 | C-02 | - | >95.00% | |
C-02 est une chimère de ciblage de protéolyse (PROTAC) composée de l'inhibiteur d'hexokinase lonidamine lié au ligand cereblon thalidomide. | ||||
| GC91582 | Pomalidomide 4'-PEG5-amine (hydrochloride) | 2357117-23-6 | >95.00% | |
Pomalidomide 4’-PEG5-amine is a PEGylated form of the cereblon (CRBN) inhibitor pomalidomide . | ||||
| GC91584 | Pomalidomide 4'-alkylC6-amine (hydrochloride) | 2375194-37-7 | >98.00% | |
Pomalidomide 4'-alkylC6-amine is a building block in the synthesis of proteolysis-targeting chimeras (PROTACs) and a derivative of the cereblon inhibitor pomalidomide . | ||||
| GC91586 | PROTAC RAF Degrader 1 | 2413035-41-1 | >98.00% | |
PROTAC RAF degrader 1 is a proteolysis-targeting chimera (PROTAC) that contains the inhibitor of mutant V600E and wild-type B-RAF vemurafenib (PLX4032; ) conjugated to VHL ligand 1 . | ||||
| GF04054 | PROTAC CDK9 degrader-4 | 2411021-01-5 | >95.00% | |
PROTAC CDK9 degrader-4 is a PROTAC protein degrader that targets CDK9 (cyclin-dependent kinase 9). | ||||
